Skip to content
Back Home

The most comprehensive Active Pharmaceutical Ingredient Sourcing Database

The most comprehensive Active Pharmaceutical Ingredient Sourcing Database

  • Find APIs
    • API Search
    • API Index
  • Get listed
  • Account
    • Log In
    • Create an Account
  • Buy GMP Audit Reports
  • Statistics
    • Statistics
    • New listed API manufacturers
    • Last searched APIs
    • Monthly Statistics 2019
    • Monthly Statistics 2018
    • Monthly Statistics 2017
    • Monthly Statistics 2016
    • Monthly Statistics 2015
    • New APIs added 2020
    • New APIs added 2019
    • New APIs added 2018
    • New APIs added 2017
    • New APIs added 2016
    • New APIs added 2015
    • New APIs added 2014
  • Contact
APIs December 2018
Home » Monthly Statistics 2018 » The Top 19 Searched APIs in December 2018

The Top 19 Searched APIs in December 2018

January 22, 2019  in Monthly Statistics 2018  tagged Amoxicillin / Cefdinir / Dabigatran / Dydrogesterone / Empagliflozin / Eribulin / Esomeprazole / Ethaverine / Ibuprofen / L-Selenomethionine / Mifepristone / Nabilone / Nadifloxacin / nalidixic acid / norfloxacin / Pregabalin / Rifaximin / Rivaroxaban / Zilpaterol

The top 20 searched APIs in December 2018:

  1. Amoxicillin
  2. Pregabalin
  3. Rivaroxaban
  4. L-Selenomethionine
  5. Mifepristone
  6. Nadifloxacin
  7. Rifaximin
  8. Nalidixic Acid
  9. Ibuprofen
  10. Esomeprazole
  11. Nabilone
  12. Eribulin
  13. Dabigatran
  14. Zilpaterol
  15. Empagliflozin
  16. Dydrogesterone
  17. Ethaverine
  18. Norfloxacin
  19. Cefdinir

Share this:

  • LinkedIn
  • Email
  • Facebook
  • More
  • Pinterest
  • WhatsApp
  • Twitter

Leave a comment Cancel reply

You must be logged in to post a comment.


Post navigation

  • ← Statistics November 2018
  • Qualit-e Cloud →

Join our Mailing List

Pages

Account
API Database
Contact
Get Listed
Statistics
Website Information

Contact
Site notice
Disclaimer
Terms & Conditions

· © 2025 API Sourcing · Powered by · Designed with the Customizr theme ·